Clinical Trials Register

Trials with a EudraCT protocol (202)
Paediatric studies in scope of Art45 of the Paediatric Regulation (0)

202 result(s) found for: Coronary Artery Disease (CAD). Displaying page 5 of 11.

EudraCT Number: 2006-000192-14

Sponsor Protocol Number: TMC-CAN-05-02

Start Date*: 2006-12-21

Sponsor Name:The Medicines Company

Full Title: A Clinical Trial Comparing Cangrelor To Clopidogrel In Subjects Who Require Percutaneous Coronary Intervention

Medical condition: Subjects with coronary atherosclerosis who require PCI (with or without stent).

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10011093	Coronary atherosclerosis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: AT (Prematurely Ended) ES (Completed) DE (Completed) IT (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2004-005002-68

Sponsor Protocol Number: DXV405

Start Date*: 2005-11-03

Sponsor Name:Amersham Health SA (Parte de GE Healthcare Ltd. y sus filiales)

Full Title: Estudio multicéntrico, aleatorizado, doble ciego, paralelo y de fase IV para comparar los efectos en la función renal del medio de contraste no iónico, isosmolar, iodixanol 320 mgI/ml (VisipaqueTM)...

Medical condition: Subjects with impaired renal function and diabetes mellitus undergoing coronary angiography.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.0		10061835		Pt

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2019-002226-79

Sponsor Protocol Number: AUGEAS

Start Date*: Information not available in EudraCT

Sponsor Name:Region Skåne

Full Title: A 30-day, randomized, evalUator-blind, controlled, multi-centre, parallel Group, phase III study to evaluate the Effect of a Low Maintenance Dose TicAgrelor Regimen versus Standard Dose Clopidogrel...

Medical condition: Coronary Artery Disease (CAD)

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10007541 - Cardiac disorders	10011078	Coronary artery disease	PT
	20.0	10007541 - Cardiac disorders	10072685	Microvascular coronary artery disease	PT
	21.1	10027433 - Metabolism and nutrition disorders	10067585	Type 2 diabetes mellitus	PT
	21.1	10042613 - Surgical and medical procedures	10065608	Percutaneous coronary intervention	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Prematurely Ended) IT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2021-002557-29

Sponsor Protocol Number: SK_DMDPA-03

Start Date*: 2021-10-25

Sponsor Name:Synektik Spółka Akcyjna

Full Title: A Phase III Study of [11C]-DMDPA Tracer for Positron Emission Tomography PET-CT Myocardial Perfusion Imaging (MPI).

Medical condition: Known or suspected acute coronary syndrome

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10007541 - Cardiac disorders	10011078	Coronary artery disease	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: PL (Completed)

Trial results: (No results available)

EudraCT Number: 2011-000190-31

Sponsor Protocol Number: MEDCOR2011

Start Date*: 2011-05-27

Sponsor Name:Therabel Pharmaceuticals Ltd

Full Title: Double-blind parallel placebo-controlled study to evaluate the effect of Molsidomine on the Endothelial Dysfunction in patients with stable angina pectoris undergoing a percutaneous CORonary interv...

Medical condition: Patients with stable angina undergoing elective PCI, used an add-on treatment on standard care therapy, molsidomine or placebo to improve the endothelial function (12 months treatment)

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10007541 - Cardiac disorders	10011079	Coronary artery disease NOS	LLT
	14.1	10007541 - Cardiac disorders	10007541	Cardiac disorders	SOC

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed)

Trial results: Removed from public view

EudraCT Number: 2007-007723-40

Sponsor Protocol Number: 0974-034

Start Date*: 2008-04-25

Sponsor Name:Merck Sharp & Dohme (Europe) Inc.

Full Title: A Multicenter, Randomized, Double-Blind, Active- and Placebo-Controlled, Period Crossover Study to Evaluate the Safety and Efficacy of MK-0974 in the Treatment of Acute Migraine in Patients With St...

Medical condition: migraine, coronary artery disease

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10027599	Migraine	LLT
	9.1		10011078	Coronary artery disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed) AT (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2021-000823-11

Sponsor Protocol Number: TIMO

Start Date*: 2023-03-09

Sponsor Name:Sahlgrenska University Hospital Gothenburg

Full Title: Ticagrelor monotherapy after coronary stenting in patients with acute myocardial infarction. A prospective single-centre, single-arm phase II study

Medical condition: Antiplatelet therapy in patients who undergo coronary artery stenting due to coronary artery disease (CAD) or acute coronary syndrome (ACS). The present study will examine whether ticagrelor, as mo...

Disease:	Version	SOC Term	Classification Code	Term	Level
	22.1	100000004849	10048560	Coronary artery disease aggravated	LLT
	20.0	100000004849	10071111	Non ST segment elevation acute coronary syndrome	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2015-004825-14

Sponsor Protocol Number: D1680C00016

Start Date*: 2016-05-04

Sponsor Name:AstraZeneca AB

Full Title: A 24-Week, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Effects of Saxagliptin, Saxagliptin Combined with Dapagliflozin, and Sitagliptin in Pat...

Medical condition: Patients with type 2 diabetes mellitus and heart failure

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	18.1	10007541 - Cardiac disorders	10011078	Coronary artery disease	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Prematurely Ended) HU (Completed) BG (Completed) RO (Completed)

Trial results: View results

EudraCT Number: 2005-001890-83	Sponsor Protocol Number: P03573	Start Date*: 2006-03-09
Sponsor Name:Schering-Plough Research Institute
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention (Thrombin Receptor Anta...
Medical condition: Subjects with symptoms of Coronary Heart Disease
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: SE (Prematurely Ended) BE (Completed) IT (Completed) DE (Completed)
Trial results: View results

EudraCT Number: 2011-001245-32

Sponsor Protocol Number: PGX-III-AP-002

Start Date*: 2011-10-19

Sponsor Name:Forest Laboratories, Inc.

Full Title: A Phase 3, Randomized, Double-Blind Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)

Medical condition: Coronary Artery Disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.0	10007541 - Cardiac disorders	10011078	Coronary artery disease	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed) NL (Prematurely Ended)

Trial results: View results

EudraCT Number: 2006-001430-40	Sponsor Protocol Number: 012-06	Start Date*: 2007-05-04
Sponsor Name:University Hospital Department of Cardiology
Full Title: Tiral of Invasive versus Medical therapy of Early coronary artery disease in Diabetes (TIME-DM)
Medical condition: The prevalence of type II diabetes is increasing rapidly, contributing importantly to a new "epidemic" of coronary artery disease (CAD). Atherosclerosis accounts for 65-80% of all death among diabe...
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: DE (Ongoing)
Trial results: (No results available)

EudraCT Number: 2022-002589-34

Sponsor Protocol Number: FLECA-ED

Start Date*: 2022-12-16

Sponsor Name:WinMedica S.A.

Full Title: Μία προοπτική, πολυκεντρική, τυχαιοποιημένη, κλινική δοκιμή για την ασφάλεια και την αποτελεσματικότητα της Φλεκαϊνίδης έναντι της Αμιωδαρόνης για την καρδιοανάταξη της παροξυσμικής Κολπικής Μαρμαρ...

Medical condition: Καρδιοανάταξη της παροξυσμικής κολπικής μαρμαρυγής στο Τμήμα Επειγόντων Περιστατικών σε ασθενείς με στεφανιαία νόσο χωρίς υπολειπόμενη ισχαιμία και κλάσμα εξώθησης > 35%.

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10007541 - Cardiac disorders	10003661	Atrial fibrillation paroxysmal	LLT
	20.0	10007541 - Cardiac disorders	10011078	Coronary artery disease	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GR (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2011-002507-15

Sponsor Protocol Number: GS-US-259-0116

Start Date*: 2012-06-22

Sponsor Name:Gilead Sciences, Inc.

Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects with a History of Chronic Angina Who Undergo Percutaneo...

Medical condition: Coronary artery disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	17.0	10007541 - Cardiac disorders	10011078	Coronary artery disease	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) SE (Completed) CZ (Completed) AT (Completed) GB (Completed) BE (Completed) NL (Completed) ES (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2011-001488-40

Sponsor Protocol Number: CCFMS181/211

Start Date*: 2011-09-01

Sponsor Name:FONDAZIONE MONZINO CENTRO CARDIOLOGICO

Full Title: Antiplatelet effect of low doses of aspirin taken every 12 hours in patients undergoing coronary artery bypass graft and / or aortic valve replacement surgery with bioprostheses

Medical condition: Coronary Atheroclerosis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10007541 - Cardiac disorders	10003211	Arteriosclerosis coronary artery	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2005-003013-32

Sponsor Protocol Number: GE IDE No. A01005

Start Date*: 2005-11-08

Sponsor Name:Deutsches Herzzentrum München

Full Title: PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED; MULTICENTER TRIAL OF BIVALIRUDIN AND UN-FRACTIONATED HEPARIN IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS

Medical condition: Coronary Artery Disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10011099	Coronary disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2012-001989-15

Sponsor Protocol Number: HomRate04_2012

Start Date*: 2012-09-17

Sponsor Name:Universität des Saarlandes

Full Title: A randomised, placebo controlled, double blind, cross-over, single center clinical Study to investigate the effect of heart rate reduction with ivabradine on endothelial function and vascular stiff...

Medical condition: Stable coronary heart disease.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10007541 - Cardiac disorders	10068617	Coronary heart disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2008-006447-40

Sponsor Protocol Number: CSPP100A2366

Start Date*: 2009-02-23

Sponsor Name:Novartis Farmacéutica

Full Title: Estudio multicéntrico, aleatorizado, doble ciego, con grupos paralelos y de 104 semanas de duración, para evaluar la eficacia de aliskiren en la progresión de la aterosclerosis en pacientes con enf...

Medical condition: Progresión de la aterosclerosis en pacientes con enfermedad arterial coronaria

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9		10011076	Coronary artery atherosclerosis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed) IT (Completed) FR (Completed) DE (Completed) BE (Completed)

Trial results: View results

EudraCT Number: 2008-001352-51

Sponsor Protocol Number: 07-116

Start Date*: 2009-01-23

Sponsor Name:Portola Pharmaceuticals Inc.

Full Title: A Randomized, Double-Blind, Active-Controlled Trial to Evaluate Intravenous and Oral PRT060128, a Selective and Reversible P2Y12-Receptor Inhibitor, vs. Clopidogrel, as a Novel Antiplatelet Therapy...

Medical condition: Adjunctive antiplatelet prior, during and after non-urgent percutaneous coronary intervention (PCI) in patients with coronary artery disease

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10065608	Percutaneous coronary intervention	LLT
	9.1		10011078	Coronary artery disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) AT (Completed)

Trial results: View results

EudraCT Number: 2017-002055-28

Sponsor Protocol Number: SK-DMDPA-02

Start Date*: 2017-10-13

Sponsor Name:Synektik Spółka Akcyjna

Full Title: Safety and dose optimization for [11C] DMDPA as a PET imaging agent for evaluation of myocardial perfusion in subjects with known or suspected coronary artery disease (CAD).

Medical condition: known or suspected coronary artery disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10007541 - Cardiac disorders	10011078	Coronary artery disease	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: PL (Completed)

Trial results: (No results available)

EudraCT Number: 2014-000457-36

Sponsor Protocol Number: 14-006

Start Date*: 2015-03-10

Sponsor Name:CHU CAEN

Full Title: A comparative dynamic study of myocardial perfusion reserve explored by cardiac WATER labelled O-15 -PET vs Tc99mibi D-SPECT in coronAry arterY disease. Protocol WATER -DAY

Medical condition: Patient suspect d’une maladie coronaire et/ou syndrome coronarien ST-

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	17.1	100000004849	10011099	Coronary disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Completed)

Trial results: View results

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA

Clinical trials for Coronary Artery Disease (CAD)